Zusammenfassung
Hintergrund: Die onkologische Rehabilitation ist integraler Bestandteil der Versorgung krebskranker Menschen. Nach einer dreiwöchigen stationären Rehabilitation mit multimodalem und integrativem Ansatz wurden die Effekte auf Belastungen und Lebensqualität der Patienten überprüft. Patienten und Methoden: 74 Krebspatienten erhielten ein komplexes Therapieprogramm, das Therapien zur Verbesserung der funktionalen Gesundheit, zur Reduktion psychosozialer Belastungen und komplementäre Massnahmen beinhaltete. Der Erfolg der Therapie wurde mit validierten Fragebögen am Abschluss der Rehabilitation (T2) und 3 Monate danach (T3) bestimmt. Ergebnisse: Es zeigte sich eine signifikante Besserung von Distress, Angst, Depression, Fatigue und Lebensqualitätsfunktionsskalen zum Zeitpunkt T2 und T3. Von T2 nach T3 war der Therapieeffekt rückläufig, ohne die Werte von T1 zu erreichen. Schlussfolgerungen: Eine multimodale, integrative onkologische Rehabilitation führt zu einer über 3 Monate anhaltenden Besserung des subjektiven Befindens der Patienten. Dieses Therapiekonzept sollte in einer Folgestudie mit einer Standardrehabilitation verglichen werden.
Literatur
1.
Krebsliga Schweiz
. Krebs in der Schweiz-eine Übersicht
. Bern
; 2017
.2.
Scott
DA
, Mills
M
, Black
A
, Cantwell
M
, Campbell
A
, Cardwell
CR
, et al. Multidimensional rehabilitation programmes for adult cancer survivors
. Cochrane Database Syst Rev
. 2013
Mar
;3
(3
):CD007730
.
[PubMed]
1469-493X3.
van Weert
E
, Hoekstra-Weebers
J
, Grol
B
, Otter
R
, Arendzen
HJ
, Postema
K
, et al. A multidimensional cancer rehabilitation program for cancer survivors: effectiveness on health-related quality of life
. J Psychosom Res
. 2005
Jun
;58
(6
):485
–96
.
[PubMed]
0022-39994.
Mewes
JC
, Steuten
LM
, Ijzerman
MJ
, van Harten
WH
. Effectiveness of multidimensional cancer survivor rehabilitation and cost-effectiveness of cancer rehabilitation in general: a systematic review
. Oncologist
. 2012
;17
(12
):1581
–93
.
[PubMed]
1083-71595.
Ture
M
, Angst
F
, Aeschlimann
A
, Renner
C
, Schnyder
U
, Zerkiebel
N
, et al. Short-term effectiveness of inpatient cancer rehabilitation: A longitudinal controlled cohort study
. J Cancer
. 2017
Jul
;8
(10
):1717
–25
.
[PubMed]
0378-23606.
Gudbergsson
SB
, Dahl
AA
, Loge
JH
, Thorsen
L
, Oldervoll
LM
, Grov
EK
. What is covered by “cancer rehabilitation” in PubMed? A review of randomized controlled trials 1990-2011
. J Rehabil Med
. 2015
Feb
;47
(2
):97
–106
.
[PubMed]
1650-19777.
Weis
J
, Moser
MT
. Goal-oriented evaluation of inpatient rehabilitation programs for women with breast cancer (ZESOR-study). In: Jäckel
WH
, Bengel
J
, Herdt
JE
, editors. Res Rehabil. Results from a Res. Netw. Southwest Ger
. Stuttgart
: Schattauer
; 2006
.8.
Speck
RM
, Courneya
KS
, Mâsse
LC
, Duval
S
, Schmitz
KH
. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis
. J Cancer Surviv
. 2010
Jun
;4
(2
):87
–100
.
[PubMed]
1932-22599.
Baumann
FT
: Physical exercise programs following cancer treatment.
European Review of Aging and Physical Acitivity. 2013
; DOI .10.
Hayes
S
, Spence
R
, Galvao
D
, Newton
R
: Australian Association for Exercise and Sport Science Position Stand: Optimising cancer outcomes through exercise. Journal of Science and Medicine in Sport/Sports Medicine Australia 2009
; 12:428-434.11.
Meneses-Echávez
JF
, González-Jiménez
E
, Ramírez-Vélez
R
. Supervised exercise reduces cancer-related fatigue: a systematic review
. J Physiother
. 2015
Jan
;61
(1
):3
–9
.
[PubMed]
1836-955312.
Hilfiker
R
, Meichtry
A
, Eicher
M
, et al.: Exercise and other non-pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment: a systematic review incorporating an indirect-comparisons meta-analysis.
DOI:13.
Tomlinson
D
, Diorio
C
, Beyene
J
, Sung
L
. Effect of exercise on cancer-related fatigue: a meta-analysis
. Am J Phys Med Rehabil
. 2014
Aug
;93
(8
):675
–86
.
[PubMed]
0894-911514.
Heim
ME
, Schröter
T
, Wünnenberg
E
, Werner
B
, Bösch
M
, Keller
G
. Ambulante integrative onkologische Rehabilitation: ein Pilotprojekt in der Schweiz
. Schweiz Z Ganzheitsmed
. 2012
;24
(6
):367
–70
. 15.
Cramer
H
, Haller
H
, Paul
A
, Dobos
G
. Mind-body-Medizin bei Krebs
. Forum
. 2017
;32
(5
):406
–10
. 0015-832116.
Satija
A
, Bhatnagar
S
. Complementary therapies for symptom management in cancer patients
. Indian J Palliat Care
. 2017
Oct-Dec
;23
(4
):468
–79
.
[PubMed]
0973-107517.
Carlson
LE
, Zelinski
E
, Toivonen
K
, Flynn
M
, Qureshi
M
, Piedalue
KA
, et al. Mind-body therapies in cancer: what ist the latest evidence?
Curr Oncol Rep
. 2017
Aug
;19
(10
):67
.
[PubMed]
1523-379018.
Rostock
M
, Naumann
J
, Guethlin
C
, Guenther
L
, Bartsch
HH
, Walach
H
. Classical homeopathy in the treatment of cancer patients—a prospective observational study of two independent cohorts
. BMC Cancer
. 2011
Jan
;11
(1
):19
.
[PubMed]
1471-240719.
Frass
M
, Friehs
H
, Thallinger
C
, Sohal
NK
, Marosi
C
, Muchitsch
I
, et al. Influence of adjunctive classical homeopathy on global health status and subjective wellbeing in cancer patients - A pragmatic randomized controlled trial
. Complement Ther Med
. 2015
Jun
;23
(3
):309
–17
.
[PubMed]
0965-229920.
Mehnert
A
, Müller
D
, Koch
U
. Die deutsche Version des NCCN Distress-Thermometers-Empirische Prüfung eines Screening Instruments zur Erfassung psychosozialer Belastung bei Krebspatienten
. Z Psychiatr Psychol Psychother
. 2006
;54
(3
):213
–23
. 1661-474721.
Herrmann
C
. International experiences with the Hospital Anxiety and Depression Scale—a review of validation data and clinical results
. J Psychosom Res
. 1997
Jan
;42
(1
):17
–41
.
[PubMed]
0022-399922.
Smets
EM
, Garssen
B
, Bonke
B
, De Haes
JC
. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue
. J Psychosom Res
. 1995
Apr
;39
(3
):315
–25
.
[PubMed]
0022-399923.
Aaronson
NK
, Ahmedzai
S
, Bergman
B
, Bullinger
M
, Cull
A
, Duez
NJ
, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology
. J Natl Cancer Inst
. 1993
Mar
;85
(5
):365
–76
.
[PubMed]
0027-887424.
Michelson
H
, Bolund
C
, Nilsson
B
, Brandberg
Y
; Helena Michelson, Christina Bolund
. Health-related quality of life measured by the EORTC QLQ-C30—reference values from a large sample of Swedish population
. Acta Oncol
. 2000
;39
(4
):477
–84
.
[PubMed]
0284-186X25.
Mitchell
AJ
. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders
. J Clin Oncol
. 2007
Oct
;25
(29
):4670
–81
.
[PubMed]
0732-183X26.
Schwarz
R
, Krauss
O
, Hinz
A
. Fatigue in the general population
. Onkologie
. 2003
Apr
;26
(2
):140
–4
.
[PubMed]
0378-584X27.
Walker
J
, Postma
K
, McHugh
GS
, Rush
R
, Coyle
B
, Strong
V
, et al. Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients
. J Psychosom Res
. 2007
Jul
;63
(1
):83
–91
.
[PubMed]
0022-399928.
Baumann
FT
, Bieck
O
, Oberste
M
, Kuhn
R
, Schmitt
J
, Wentrock
S
, et al. Sustainable impact of an individualized exercise program on physical activity level and fatigue syndrome on breast cancer patients in two German rehabilitation centers
. Support Care Cancer
. 2017
Apr
;25
(4
):1047
–54
.
[PubMed]
0941-435529.
Oncosuisse: Nationales Krebsprogramm für die Schweiz 2011-2015, Bern
2011
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
